Acta Oncologica

Papers
(The H4-Index of Acta Oncologica is 18. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-03-01 to 2025-03-01.)
ArticleCitations
Cardiovascular risk factors, radiation therapy, and myocardial infarction among lymphoma survivors62
Health-related quality of life among family caregivers of oesophageal cancer survivors one year after curative intended treatment – a nationwide population-based study37
Blood biomarkers for neuroaxonal injury and astrocytic activation in chemotherapy-induced peripheral neuropathy37
Bone versus soft-tissue setup in proton therapy for patients with oesophageal cancer36
Importance of tumor volume, overall treatment time and fractionation sensitivity for p16-positive and p16-negative oropharyngeal tumors33
Circulating tumor DNA (ctDNA) in adjuvant therapy of early stage colon cancer: current status and future perspectives32
Quality of life and mental health in real-world patients with resected stage III/IV melanoma receiving adjuvant immunotherapy29
Temporal trends in lung cancer survival: a population-based study29
Temporal changes in childhood cancer incidence and survival by stage at diagnosis in Australia, 2000–201726
First-line Treatment Patterns and Outcomes in Advanced Non-Small Cell Lung Cancer in Sweden: A Population-based Real-world Study with Focus on Immunotherapy25
FOLFIRI in advanced platinum-resistant/refractory small-cell lung cancer: a retrospective study24
Time trends in the use of curative treatment in men 70 years and older with nonmetastatic prostate cancer21
Patient-centered development ofEmbrace Pain: an online acceptance and commitment therapy intervention for cancer survivors with chronic painful chemotherapy-induced peripheral neuropathy21
Co-occurrence of symptoms after radiochemotherapy in locally advanced cervix cancer patients: a cluster analysis20
Benefit finding, posttraumatic growth and health-related quality of life in long-term cancer survivors: a prospective population-based study20
5-Year survival in Danish patients with advanced non-small cell lung cancer treated with immune checkpoint inhibitor monotherapy20
A study of microRNAs as new prognostic biomarkers in anal cancer patients19
ctDNA-guided adjuvant treatment after radical-intent treatment of metastatic spread from colorectal cancer—the first interim results from the OPTIMISE study18
Acute normal tissue responses in a murine model following fractionated irradiation of the head and neck with protons or X-rays18
0.12173795700073